. . . . . . . . . "nipent is indicated as single agent treatment for both untreated and alpha interferon refractory hairy cell leukemia patients with active disease as defined by clinically significant anemia neutropenia thrombocytopenia or disease related symptoms" . . . . . . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB" . "hgaZ68b+6l6k4HY5Vl4uXENGEpD7ahUW0hy3ed9KSuWn7nnScIT+I/snoRWs+O/FWoLrpnxF/aY2+FFkREHBQpxCZR2MNZM4sDauPivK9eFES0uy3nA59mSGgorgxWqLkV86YALQbsXoKzelaJQDYuabXd1eNPwAqbKaOO/8SwU=" . . "2021-06-12T16:19:15.117+02:00"^^ . . . . .